$-0.39
(Market cap
$3,203 Mln
Recently Viewed
Clear AllMarket cap
$3,203 Mln
Revenue (TTM)
$582 Mln
P/E Ratio
31.8
P/B Ratio
8.3
Div. Yield
1.8 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
0.3 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
23.7
Debt to Equity
0.2
Book Value
$7.7
EPS
$2.1
Face value
--
Shares outstanding
48,614,692
CFO
$891.81 Mln
EBITDA
$953.10 Mln
Net Profit
$714.22 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Exponent (EXPO)
| -5.2 | -0.7 | -11.3 | -17.6 | -12.4 | -8.1 | 10.0 |
|
BSE Sensex
| -9.5 | 5.5 | -6.0 | -4.3 | 8.7 | 9.9 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Exponent (EXPO)
| -22.0 | 1.2 | -11.2 | -15.1 | 29.7 | 30.5 | 36.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Exponent (EXPO)
|
65.9 | 3,202.7 | 582.0 | 106.0 | 25.3 | 26.1 | 31.8 | 8.3 |
| 65.0 | 7,282.3 | 3,015.8 | 1,088.4 | 54.0 | 13.6 | 7 | 0.9 | |
| 110.1 | 4,530.4 | 5,261.2 | 199.7 | 11.4 | 86.3 | 23.4 | 16.4 | |
| 16.5 | 7,278.8 | 59.8 | -136.0 | 7,289.8 | -272.8 | -- | 20.0 | |
| 30.4 | 4,754.1 | 2,087.7 | 251.0 | 16.5 | 27.2 | 19.7 | 5.2 | |
| 184.2 | 5,548.7 | 3,788.9 | 270.9 | 11.1 | 13.6 | 22.5 | 3.2 | |
| 169.9 | 6,585.9 | 1,874.8 | 278.9 | 21.4 | 22.2 | 24.3 | 4.9 | |
| 21.1 | 4,440.6 | 1,635.2 | 67.9 | 4.8 | 8.9 | 68 | 5.1 | |
| 150.5 | 5,215.6 | 2,698.1 | 310.4 | 24.7 | 25.9 | 17.8 | 4.3 | |
| 22.7 | 4,101.3 | 2,281.5 | -53.0 | 7.0 | -5.7 | -- | 4.8 |
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health.... It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California. Read more
President, CEO & Director
Dr. Catherine Ford Corrigan P.E., Ph.D.
President, CEO & Director
Dr. Catherine Ford Corrigan P.E., Ph.D.
Headquarters
Menlo Park, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Exponent Inc (EXPO) is $65.88 (NASDAQ) as of 24-Apr-2026 16:00 EDT. Exponent Inc (EXPO) has given a return of -12.43% in the last 3 years.
The P/E ratio of Exponent Inc (EXPO) is 31.83 times as on 24-Apr-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
33.16
|
9.00
|
|
2024
|
42.22
|
10.93
|
|
2024
|
--
|
--
|
|
2023
|
45.14
|
12.72
|
|
2023
|
--
|
--
|
The 52-week high and low of Exponent Inc (EXPO) are Rs 81.95 and Rs 63.25 as of 26-Apr-2026.
Exponent Inc (EXPO) has a market capitalisation of $ 3,203 Mln as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Exponent Inc (EXPO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.